Menu
  • Join
  • Login
  • Contact
 

Search abstracts


NICORANDIL IMPROVE PROGNOSIS OF CARDIAC ARREST PATIENT: A LARGE-SCALE MEDICAL INFORMATION ANALYSIS

  • At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
  • Type: Poster
  • By: NIIMURA, Takahiro (Tokushima University Graduate School of Biomedical Sciences, Department of Clinical Pharmacology and Therapeutics, Japan)
  • Co-author(s): Takahiro Niimura: Department of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
    Yoshito Zamami: Department of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan;Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan
    Yuki Izawa-Ishizawa: AWA Support Center, Tokushima University, Tokushima, Japan
    Mitsuhiro Goda : Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan
    Kenshi Takechi: Clinical Trial Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan
    Masayuki Chuma: Clinical Trial Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan
    Keijo Fukushima: Department of Pharmacology for Life Sciences, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
    Yuya Horinouchi: Department of Pharmacology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan
    Yasumasa Ikeda: Department of Pharmacology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan
    Hiromichi Fujino: Department of Pharmacology for Life Sciences, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
    Koichiro Tsuchiya: Department of Medical Pharmacology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
    Keisuke Ishizawa: Department of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan;Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan
  • Abstract:

    Background

    The survival rate of patients with cardiac arrest in Japan is around 10%. Because the main cause of poor survival prognosis is encephalopathy, development of a therapeutic drug for improving brain damage is desired. Nicorandil, a drug for the treatment of angina pectoris, has been reported to have a neuroprotective effect, but its effect ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses